Xiao-Hui Zhang, MD
Peking University Institute of Hematology, Peking University People's Hospital · eking University Institute of Hematology, Peking University People's Hospital · Peking University People's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Xiao-Hui Zhang, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:20 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07905066 · Hemophagocytic Lymphohistiocytosis After Allogeneic Stem Cell TransplantationPeking University People's Hospital · recruiting · Hemophagocytic Lymphohistiocytosis (HLH) · principal investigator
- N/ANCT07569055 · Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell TransplantationPeking University People's Hospital · recruiting · Invasive Fungal Disease, Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) · principal investigator
- N/ANCT07113730 · The Kinetics Profiling of Immune Reconstitution and Clinical OutcomesPeking University People's Hospital · not yet recruiting · Chronic Myelomonocytic Leukemia (CMML), Immune Reconstitution · principal investigator
- N/ANCT07070193 · Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic StrokePeking University People's Hospital · not yet recruiting · Immune Thrombocytopenia (ITP), Acute Ischemic Stroke · principal investigator
- N/ANCT07068425 · Longitudinal Observational Study on Immune ThrombocytopeniaPeking University People's Hospital · not yet recruiting · Immune Thrombocytopenia (ITP) · principal investigator
- Ph2NCT07065968 · The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)Peking University People's Hospital · recruiting · Immune Thrombocytopenia (ITP) · principal investigator
- N/ANCT06727669 · Longitudinal Cohort of Thrombosis and Hemostasis DiseasesPeking University People's Hospital · recruiting · Immune Thrombocytopenia, Thrombotic Thrombocytopenic Purpura, Hemophilia A, Acquired · principal investigator
- Ph2NCT06176911 · The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT06176235 · Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune ThrombocytopeniaPeking University People's Hospital · withdrawn · Immune Thrombocytopenia · principal investigator
- Ph2NCT05494307 · The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT05471050 · The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT05459649 · Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT05353673 · The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia, Blood Coagulation Disorders, Thrombocytopenia · principal investigator
- Ph2NCT05302024 · Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT05279872 · A Study of Zanubrutinib in Patients With ITPPeking University People's Hospital · completed · Immune Thrombocytopenia, Bruton Tyrosine Kinase · principal investigator
- Ph2NCT05281068 · The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaPeking University People's Hospital · unknown · ITP, Immune Thrombocytopenia · principal investigator
- Ph1/Ph2NCT05124028 · A Study of Orelabrutinib in Patients With ITPPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- N/ANCT05116423 · Machine-learning Based Prediction Model in Primary Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia, ITP · principal investigator
- N/ANCT04214951 · A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune ThrombocytopeniaPeking University People's Hospital · unknown · Corticosteroid-resistant or Relapsed ITP
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.